BTIG raises target for Avita Medical stock from USD 11.00 to USD 15.00

 

Second-quarter revenue reached USD 21.70 million, up 18.00 percent year over year. Avita Medical stock is tied to 2026 guidance of USD 86 million to USD 89 million.

Target revision and revenue growth

• BTIG lifted its Avita Medical target on October 12, 2026.
• Second-quarter revenue reached USD 21.70 million, up 18.00 percent year over year.
• Full-year 2026 revenue guidance stands at USD 86 million to USD 89 million.

https://www.ad-hoc-news.de/boerse/news/nebenwerte/btig-raises-target-for-avita-medical-stock-from-usd-11-00-to-usd-15-00/70355873